| Literature DB >> 35412845 |
Yongjia Yan1, Daohan Wang1, Yubiao Liu1, Li Lu1, Xi Wang1, Zhicheng Zhao1, Chuan Li1, Jian Liu1, Weidong Li1, Weihua Fu1.
Abstract
OBJECTIVES: Although laparoscopic distal gastrectomy has been widely used for distal gastric cancer, the best functional reconstruction type has not yet been established. Based on previous experience, we propose a modified uncut Roux-en-Y anastomosis. This study aimed to compare the outcomes of different intracorporeal anastomoses after laparoscopic distal gastrectomy.Entities:
Keywords: bile reflux; gastric cancer; laparoscopic surgery; nutrition; reconstruction
Mesh:
Year: 2022 PMID: 35412845 PMCID: PMC9121732 DOI: 10.1177/10732748221087059
Source DB: PubMed Journal: Cancer Control ISSN: 1073-2748 Impact factor: 2.339
Figure 1.Modified uncut Roux-en-Y operation. (A) Gastrojejunostomy is established approximately 20 cm distal to the ligament of Treitz. Occlusion is done at 3 cm proximal to the gastrojejunostomy. Jejunojejunostomy is done between the afferent and efferent jejunal limbs approximately 10 cm distal to the ligament of Treitz and 40 cm distal to the gastrojejunostomy site. (B) We performed1-0 silk seromuscular stitches circularly around the jejunal wall (b1), and provided reinforcement using interrupted seromuscular sutures at the occlusion site (b2). (C) Postoperative upper gastrointestinal radiography was done to determine afferent recanalization. This figure shows the results of the 4 patients who accepted uncut Roux-en-Y anastomosis.
Clinicopathologic Characteristics of Patients (n = 215).
| Variable | BⅠ | BⅡ+Braun | RY | URY | |
|---|---|---|---|---|---|
| (n = 52) | (n = 103) | (n = 31) | (n = 29) | ||
| Gender | .155 | ||||
| Male | 29(55.8%) | 75(72.8%) | 20(64.5%) | 17(58.6%) | |
| Female | 23(44.2%) | 28(27.2%) | 11(35.5%) | 12(41.4%) | |
| Age (year) | 60.9 ± 9.6 | 68.0 ± 9.3# | 62.4 ± 10.6 | 61.4 ± 10.9 | <.001 |
| BMI(kg/m2) | 23.6 ± 3.7 | 23.3 ± 3.5 | 22.5 ± 2.9 | 23.1 ± 3.2 | .600 |
| ASA | .253 | ||||
| Ⅰ | 25(48.1%) | 29(28.2%) | 11(35.5%) | 7(24.1%) | |
| Ⅱ | 25(48.1%) | 68(66.0%) | 19(61.3%) | 20(69.0%) | |
| Ⅲ | 2(3.8%) | 6(5.8%) | 1(3.2%) | 2(6.9%) | |
| Previous operation history (%) | 15(28.8%) | 22(21.4%) | 8(25.8%) | 9(31.0%) | .636 |
| Comorbidity(%) | 23(44.2%) | 43(41.7%) | 9(29.0%) | 14(48.3%) | .441 |
| Tumor location | .121 | ||||
| Antrum | 38(73.1%) | 69(67.0%) | 16(51.6%) | 21(75.0%) | |
| Gastric angle | 14(26.9%) | 28(27.2%) | 12(38.7%) | 4(14.3%) | |
| Lower gastric body | 0(0.0%) | 6(5.8%) | 3(9.7%) | 3(10.7%) | |
| Tumor diameter (mm) | 20(6-60) | 40(10-85) | 30(8-60) | 35(6-70) | <.001 |
| Differentiation | .016 | ||||
| Poor | 14(26.9%) | 50(48.5%) | 18(58.1%) | 10(34.5%) | |
| Moderate | 20(38.5%) | 38(36.9%) | 8(25.8%) | 14(48.3%) | |
| Well | 18(34.6%) | 15(14.6%) | 5(16.1%) | 5(17.2%) | |
| Tumor stage | <.001 | ||||
| Ⅰ | 32(61.5%) | 24(23.3%) | 10(32.3%) | 10(34.5%) | |
| Ⅱ | 11(21.2%) | 26(25.2%) | 9 (29.0%) | 7 (24.1%) | |
| Ⅲ | 9 (17.3%) | 53(51.5%) | 12(38.7%) | 12(41.4%) | |
Values are presented as number (%), mean ± standard deviation, or median (interquartile range). BI: Billroth I; BII+Braun: Billroth II and Braun; RY: Roux-en-Y; URY: uncut Roux-en-Y.
# The difference was statistically significant between the BII+Braun and BI (P < .001), and URY (P = .026).
Comparison of the Perioperative Surgical Outcomes.
| Variable | BⅠ | BⅡ+Braun | RY | URY | |
|---|---|---|---|---|---|
| (n = 52) | (n = 103) | (n = 31) | (n = 29) | ||
| Methods | <.001 | ||||
| Laparoscopic-assisted distal gastrectomy | 6(11.5%) | 31(30.1%) | 18(58.1%) | 3(10.3%) | |
| Totally laparoscopic distal gastrectomy | 46(88.5%) | 72(69.9%) | 13(41.9%) | 26(89.7%) | |
| Operative time (min) | 216.2 ± 25.8* | 249.1 ± 37.3# | 278.8 ± 45.8 | 269.9 ± 30.2 | <.001 |
| Blood loss (mL) | 50(30-200) | 50(50-150) | 50(20-200) | 50(20-200) | .475 |
| No. of harvested lymph node | 27(16-39) | 29(16-62) | 24(16-52) | 30(16-60) | .139 |
| Time to first flatus (d) | 2(1-3) | 2(1-3) | 2(1-3) | 2(1-3) | .075 |
| Postoperative hospital stay(d) | 13(7-37) | 14(9-33) | 14(11-30) | 12(10-30) | .170 |
Values are presented as number (%), mean ± standard deviation, or median (interquartile range). BI: Billroth I; BII+Braun: Billroth II and Braun; RY: Roux-en-Y; URY: uncut Roux-en-Y; LADG: laparoscopic-assisted distal gastrectomy; TLDG: totally laparoscopic distal gastrectomy.
* The difference was statistically significant between the BI and BII+Braun (P < .001), and RY (P < .001), and URY (P < .001).
# The difference was statistically significant between the BII+Braun and RY (P = .009) and URY (P = .045)
The Clavien-Dindo Classification of Postoperative Complications.
| Variable | BⅠ | BⅡ+Braun | RY | URY | P Value |
|---|---|---|---|---|---|
| (n = 52) | (n = 103) | (n = 31) | (n = 29) | ||
| Postoperative complications | 8(15.4%) | 20(19.4%) | 6(19.4%) | 4(13.8%) | .858 |
| Grade Ⅰ | 3(5.8%) | 16(15.5%) | 4(13.0%) | 3(10.3%) | .366 |
| Fever | 3(5.8%) | 12(11.6%) | 2(6.5%) | 2(6.9%) | |
| Incision healing delay | — | 4 (3.9%) | 2(6.5%) | 1(3.4%) | |
| Grade Ⅱ | 7 (13.4%) | 19 (18.4%) | 6 (17.6%) | 4(13.8%) | .826 |
| Pulmonary infection | 2(3.8%) | 7(6.8%) | 2(6.5%) | 2(6.9%) | |
| Pancreatic fistula | 3(5.8%) | 6(5.8%) | — | 2(6.9%) | |
| Delayed gastric emptying | 2(3.8%) | 3(2.9%) | 4(13.0%) | — | |
| Duodenal stump leakage | — | 3(2.9%) | — | — | |
| Grade Ⅲ | 2(3.8%) | 6(5.8%) | 2(6.5%) | 1 (3.4%) | .885 |
| Pleural effusion | 1(1.9%) | 3(2.9%) | — | — | |
| Peritoneal effusion | — | 2(1.9%) | 1(3.2%) | 1 (3.4%) | |
| Anastomotic leakage | — | 1(1.0%) | 1(3.2%) | — | |
| Intra-abdominal bleeding | 1(1.9%) | — | — | — |
Values are presented as number (%). BI: Billroth I; BII+Braun: Billroth II and Braun; RY: Roux-en-Y; URY: Uncut Roux-en-Y.
Figure 2.Comparison of the survival curve in different groups. (A) The OS rate of the Billroth-I, Billroth-II+Braun, Roux-en-Y, and uncut Roux-en-Y anastomosis groups (P = .881). (B) The OS rate of TNM stages I, II, and III (P < .001). (C) The overall survival (OS) rate in patients with TNM stage I (P = .888). (D) The OS rate in patients with TNM stage II (P = .811). (E) The OS rate in patients with TNM stage III (P = .155).
Figure 3.Endoscopic findings and nutritional changes after laparoscopic distal gastrectomy in the 4 groups. (A) Endoscopic findings one year after surgery; (B) prognostic nutritional index (PNI); (C) albumin (g/L); (D) total lymphocyte count (109/L); (E) hemoglobin (mg/dL); and (F) total protein (g/L).
Logistic Regression Analysis of Postoperative Function and Nutrition.
| Variable | Gastritis/Esophagitis | Bile Reflux | L-PNI† | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Age (>60/<60) | 8.568 (2.834–25.902) | <.001 | 6.208 (2.356–16.361) | <.001 | 1.551 (.029–81.832) | .828 |
| Sex (male/female) | .749 (.319–1.757) | .506 | .642 (.279–1.480) | .298 | .141 (.006–3.297) | .223 |
| BMI | 1.06 (.935–1.2) | .364 | 1.031 (.918–1.157) | .609 | 1.164 (.754–1.798) | .493 |
| Size | .983 (.955–1.012) | .240 | .986 (.961–1.012) | .871 | .967 (.889–1.051) | .431 |
| Differentiation | ||||||
| Poorly | Ref | Ref | Ref | |||
| Moderately | .368 (.132–1.027) | .056 | .383 (.148–1.988) | .669 | 7.704 (.428–138.599) | .166 |
| High | .841 (.219–3.233) | .800 | .687 (.212–2.223) | .531 | 1.079 (.005–234.002) | .978 |
| The tumor node metastasis | ||||||
| I | Ref | Ref | Ref | |||
| II | 7.901 (.829–75.344) | .072 | .829 (.042–16.437) | .170 | 1.718 (.036–81.286) | .783 |
| III | 5.568 (.226–137.338) | .294 | .909 (.015–56.861) | .060 | 4.788 (.150–152.866) | .375 |
| Reconstruction | ||||||
| Billroth-Ⅰ | Ref | Ref | .003 | Ref | ||
| Billroth-Ⅱ+Braun | .764 (.279–2.090) | .600 | .4 (.127–1.258) | .117 | 1.781 (.084–37.904) | .711 |
| Roux-en-Y | .076 (.013–.442) | .004 | .018 (.001–.264) | .003 | .373 (.14–10.053) | .557 |
| Uncut Roux-en-Y | .076 (.017–.344) | .001 | .077 (.014–.436) | .004 | .033 (.001–2.196) | .112 |
The independent factors associated with gastritis, esophagitis, bile reflux, and postoperative PNI were evaluated using univariate and multivariable logistic regression models. † 50 was set as the cut-off value for PNI and classified the patients into a high-PNI (≥50) group and a low-PNI (<50) group.